title: [Fondaparinux and anesthesia].
authors.forename: J V
authors.initials: JV
authors.lastname: Llau
authors.forename: J
authors.initials: J
authors.lastname: De Andrés
authors.forename: C
authors.initials: C
authors.lastname: Gomar
authors.forename: A
authors.initials: A
authors.lastname: Gómez
authors.forename: F
authors.initials: F
authors.lastname: Hidalgo
authors.forename: L M
authors.initials: LM
authors.lastname: Torres
mesh_terms: D000765:Anesthesia, Conduction; D000075202:Contraindications; D065427:Factor Xa Inhibitors; D005343:Fibrinolytic Agents / Q000008:administration & dosage / Q000009:adverse effects / Q000493:pharmacokinetics; D000077425:Fondaparinux; D006406:Hematoma / Q000139:chemically induced / Q000517:prevention & control*; D006801:Humans; D011134:Polysaccharides / Q000008:administration & dosage / Q000009:adverse effects / Q000493:pharmacokinetics; D011183:Postoperative Complications / Q000517:prevention & control; D019106:Postoperative Hemorrhage / Q000139:chemically induced / Q000517:prevention & control*; D011677:Punctures / Q000009:adverse effects*; D012306:Risk; D013923:Thromboembolism / Q000517:prevention & control; D013997:Time Factors
chemical_list: D065427:Factor Xa Inhibitors; D005343:Fibrinolytic Agents; D011134:Polysaccharides; D000077425:Fondaparinux